SCHEMBL14554343

SCHEMBL14554343

CCN(CCNC(=O)OC(C)(C)C)c1ccc(C#N)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CKS1B P61024 1/20 0.44
SKP1 P63208 1/20 0.44
SKP2 Q13309 1/20 0.44
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
GFER P55789 1/20 0.40
MGLL Q99685 2/20 0.38
FNTA P49354 2/20 0.38
FNTB P49356 2/20 0.38
PGGT1B P53609 2/20 0.38
KCNH2 Q12809 1/20 0.38
CA12 O43570 5/20 0.38
CA1 P00915 5/20 0.38
CA2 P00918 5/20 0.38
CA9 Q16790 5/20 0.38
EGLN2 Q96KS0 2/20 0.38
BCHE P06276 1/20 0.36
STK17B O94768 1/20 0.36
STK17A Q9UEE5 1/20 0.36
PTPN11 Q06124 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14554486 0.87 CKS1B (0.55) CKS1BSKP1SKP2CCNCCDK8
SCHEMBL14484887 0.84 GFER (0.47) GFERMGLLKDM4EMAPTAOC3
SCHEMBL14554331 0.83 CKS1B (0.48) CKS1BSKP1SKP2CCNCCDK8
SCHEMBL30546398 0.81 HCAR3 (0.34) CCNCCDK8FNTAFNTBEGLN2
SCHEMBL14554497 0.80 CKS1B (0.44) CKS1BSKP1SKP2CCNCCDK8
SCHEMBL26124987 0.77 GBA1 (0.41) GFERFNTAFNTBPGGT1BKDM4E
SCHEMBL4039822 0.77 CKS1B (0.42) CKS1BSKP1SKP2CCNCCDK8
SCHEMBL12185205 0.77 EGLN2 (0.43) CA12CA1CA2CA9EGLN2
SCHEMBL26127470 0.76 HCAR3 (0.35) GFERMGLLEGLN2KDM4EMAPT
SCHEMBL8003211 0.76 DPP4 (0.47) CA12CA1CA2CA9EGLN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
WO-2023192989-A2 PHTHALAZINONE COMPOUNDS AS PARP7 INHIBITORS AZKARRA THERAPEUTICS, INC. (US) 2023-10-05 WO disclosed
WO-2013006408-A1 COMPOUNDS AND METHODS TEMPERO PHARMACEUTICALS, INC. (US) 2013-01-10 WO disclosed